Enhancing radiosensitisation of BRCA2-proficient and BRCA2-deficient cell lines with hyperthermia and PARP1-i.
about
Boosting the effects of hyperthermia-based anticancer treatments by HSP90 inhibition.The clinical benefit of hyperthermia in pancreatic cancer: a systematic review.BRCA2 protects mammalian cells from heat shock.Feasibility of on-line temperature-based hyperthermia treatment planning to improve tumour temperatures during locoregional hyperthermia.Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies.Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
P2860
Enhancing radiosensitisation of BRCA2-proficient and BRCA2-deficient cell lines with hyperthermia and PARP1-i.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Enhancing radiosensitisation o ...... with hyperthermia and PARP1-i.
@en
Enhancing radiosensitisation o ...... with hyperthermia and PARP1-i.
@nl
type
label
Enhancing radiosensitisation o ...... with hyperthermia and PARP1-i.
@en
Enhancing radiosensitisation o ...... with hyperthermia and PARP1-i.
@nl
prefLabel
Enhancing radiosensitisation o ...... with hyperthermia and PARP1-i.
@en
Enhancing radiosensitisation o ...... with hyperthermia and PARP1-i.
@nl
P2093
P2860
P50
P1476
Enhancing radiosensitisation o ...... with hyperthermia and PARP1-i
@en
P2093
H Petra Kok
Rosemarie Ten Cate
Vidhula R Ahire
P2860
P356
10.1080/02656736.2017.1324642
P577
2017-05-19T00:00:00Z